Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28076526 | 0.82 | TSHR (0.31) | TSHR | |
| SCHEMBL24991762 | 0.79 | — | — | |
| SCHEMBL17607700 | 0.79 | — | — | |
| SCHEMBL14492438 | 0.79 | TSHR (0.31) | TSHR | |
| SCHEMBL469458 | 0.79 | TSHR (0.31) | TSHR | |
| SCHEMBL19004724 | 0.78 | TSHR (0.40) | TSHR | |
| SCHEMBL109285 | 0.78 | TSHR (0.40) | TSHR | |
| SCHEMBL18823898 | 0.76 | TSHR (0.32) | TSHR | |
| SCHEMBL22662916 | 0.76 | ALDH1A1 (0.30) | TSHR | |
| SCHEMBL19068813 | 0.74 | TSHR (0.35) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200171214-A1 | BIORESORBABLE SURFACE COATING FOR DELAYING DEGRADATION | DREI LILIEN PVG GMBH & CO. KG (DE) | 2020-06-04 | — | — | US | disclosed |
| EP-3648806-A1 | BIORESORBABLE SURFACE COATING FOR DELAYING DEGRADATION | Drei Lilien PVG GmbH & Co. KG (DE) | 2020-05-13 | — | — | EP | disclosed |
| WO-2019008192-A1 | BIORESORBABLE SURFACE COATING FOR DELAYING DEGRADATION | DREI LILIEN PVG GMBH & CO. KG (DE) | 2019-01-10 | — | — | WO | disclosed |
| US-20170240525-A1 | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION | PMV PHARMACEUTICALS, INC. | 2017-08-24 | — | — | US | disclosed |
| US-8679744-B2 | Method for cleaning and isolating nucleic acid using ammonium or phosphonium cationic detergents | QIAGEN GMBH (DE) | 2014-03-25 | — | — | US | disclosed |
| EP-1570123-B1 | GRAFT COPOLYMERS AS AUXILIARIES FOR DYEING AND PRINTING TEXTILES | BASF SE (DE) | 2009-06-17 | — | — | EP | disclosed |
| EP-0858446-A1 | PHENYLCARBAMATES, PROCESSES AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND THEIR USE AS PESTICIDES AND FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1998-08-19 | — | — | EP | disclosed |
| US-5674812-A | HERBICIDES; SELECTIVITY TO GRASS WEEDS IN CORN OR RICE | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-07 | — | — | US | disclosed |
| WO-1997016415-A1 | PHENYLCARBAMATES, PROCESSES AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND THEIR USE AS PESTICIDES AND FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-05-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170240525-A1 | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION | TP53, TP53BP1, KRAS | TSHR 3846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.